Abstract 1593P
Background
Adolescent and young adults (AYA) with underlying cancer often experience multiple General Practitioner (GP) consultations before they are referred to a specialist. Certain patient groups may be at higher risk of such events, but evidence is lacking, particularly from Australia. We aimed to examine GP activity prior to cancer diagnosis in an Australian cohort of AYAs and factors associated with multiple GP consultations.
Methods
We conducted an Australian cohort study of patients aged 18–39 years with incident cancer recorded in the Victorian Cancer Registry between 2008-2022 and linkage to the Patron primary care dataset. We calculated the frequency of GP events in the year before cancer diagnosis (GP consultations, prescriptions, blood test and imaging) and the proportion of patients with multiple GP consultations (≥4) in this period. Using multivariable logistic regression models, we examined associations between multiple pre-diagnostic GP consultations and patient characteristics, including age, sex, socioeconomic status, regional or city location, culturally and linguistically diverse background and main spoken language.
Results
1,712 AYAs with cancer were identified: 276 aged 18–25 and 1,436 aged 26–39. AYAs had a mean of 3 GP consults in the six months pre-diagnosis (range 0-46), with 1,035 (60%) AYAs having a GP consultation in this period and 434 AYAs (25%) consulting a GP 4 or more times. AYAs living in regional Australia were more likely to have 4 or more consultations (adjusted odds ratio (AOR) 1.67, 95%CI 1.32-2.10, p<0.001) as were those diagnosed in more recent years, particularly between 2020-2022 (AOR 1.54, 95%CI 1.14-2.07, p=0.005). In AYAs aged 18-25 years, the most deprived patients were more likely to have multiple GP consults (AOR 3.46, 95%CI 1.55-7.72, p=0.002), with no evidence of an association was observed in AYAs aged 26-40.
Conclusions
Our findings identify AYA patient groups at higher risk of multiple GP consultations before cancer diagnosis and at risk of having a prolonged diagnostic journey. These findings could help to inform policy and prioritise early diagnosis interventions focusing on these patient groups.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
University of Melbourne Human Ethics team in the Office of Research Ethics and Integrity.
Funding
Victorian Adolescent & Young Adult Cancer Service, Peter MacCallum Cancer Centre.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1583P - Trial-level surrogacy of intermediate endpoints in adjuvant or neoadjuvant use of immune checkpoint blockade
Presenter: Luís Leite
Session: Poster session 10
1584P - Association of travel burden (TB) with colorectal cancer (CRC) outcomes in resource-limited settings (RLS)
Presenter: Saquib Banday
Session: Poster session 10
1585P - Performance status restrictions in clinical trials leading to US food and drug administration (FDA) drug approval: A cross-sectional study of a decade (2014-2023)
Presenter: Giovanni Maria Iannantuono
Session: Poster session 10
1586P - Current status of breast cancer: A comparative analysis between developed and developing countries
Presenter: Ana Isabel Martin Quesada
Session: Poster session 10
1587P - As seen through Hollywood’s lens: Cancer in movies, 2010-2020
Presenter: David Benjamin
Session: Poster session 10
1588P - Interventions to improve Herpes Zoster (HZ) vaccination rate among cancer outpatients receiving systemic treatments: A single-center real-world experience
Presenter: Sara Di Bella
Session: Poster session 10
1589P - Ramping up phase I trial recruitment: Defining potential barriers and disparities
Presenter: Burak Aktas
Session: Poster session 10
1590P - Prevalence and impact on survival of presentation to the emergency room of cancer patients: A retrospective study on real-life data
Presenter: Sonia Priou
Session: Poster session 10
1591P - Development and economic trends in new anticancer therapies licensed in the UK from 2020 to 2024
Presenter: Geetin Majhail
Session: Poster session 10
1592P - Awareness and interest of oncology professionals in sex and gender differences in cancer risk and outcome: Analysis of an ESMO Gender Medicine Task Force survey
Presenter: Berna C. Özdemir
Session: Poster session 10